Related Experiment Video
Updated: Jun 4, 2026
09:17
Using Retinal Imaging to Study Dementia
Published on: November 6, 2017
Glycated haemoglobin and cognitive decline: the Atherosclerosis Risk in Communities (ARIC) study
A L Christman1, K Matsushita, R F Gottesman
1Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, 615 North Wolfe Street, Baltimore, MD 21205, USA. andrea.christman@gmail.com
Diabetologia
|March 2, 2011
Summary
Diabetes diagnosis, not HbA1c levels alone, predicted cognitive decline in middle-aged adults. Further research is needed to understand non-glycemic factors contributing to cognitive impairment in diabetes.
Area of Science:
- Neuroscience
- Endocrinology
- Public Health
Background:
- Diabetes mellitus is a growing global health concern.
- Cognitive impairment is a potential complication of diabetes.
- Glycemic control, measured by HbA1c, is crucial in diabetes management.
Purpose of the Study:
- To investigate the association between diabetes, hyperglycemia (HbA1c), and cognitive function changes.
- To determine if HbA1c levels predict cognitive decline independently of diabetes status.
Main Methods:
- Prospective cohort study of 8,442 non-diabetic and 516 diabetic participants (ARIC study).
- Assessed HbA1c and cognitive function (DSST, DWRT, WFT) over 6 years.
- Used adjusted logistic regression models accounting for demographic, lifestyle, and metabolic factors.
Main Results:
- Diagnosed diabetes was linked to cognitive decline in the Digit Symbol Substitution Test (DSST).
- HbA1c levels did not independently predict cognitive decline in individuals with or without diabetes.
- No significant trends in cognitive decline were observed for DWRT or WFT based on HbA1c or diabetes status.
Conclusions:
- Diabetes diagnosis, rather than HbA1c levels, was associated with cognitive decline in this cohort.
- Hyperglycemia (HbA1c) did not provide additional predictive value for cognitive decline beyond diabetes status.
- Non-glycemic factors associated with diabetes require further investigation for their role in cognitive decline.
Related Concept Videos
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:30Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...